Moreover, since peripheral systemic inflammation can lead to microglia activation in the brain, in vivo assessment of microglia activity before and after ECT by 18-kDa translocator protein (TSPO) PET can help to further clarify whether ECT treats schizophrenia by reducing neuroinflammation [59, 60]. This evidence concerns the gene TSPO and schizophrenia.